載入...
Effective innate and adaptive anti-melanoma immunity through localized TLR-7/8 activation
Intratumoral immune activation can induce local and systemic anti-tumor immunity. Imiquimod is a cream-formulated, TLR-7 agonist that is FDA-approved for the treatment of non-melanoma skin cancers, but has limited activity against melanoma. We studied the anti-tumor activity and mechanism of action...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4201984/ https://ncbi.nlm.nih.gov/pubmed/25252955 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1401160 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|